Proposed Drug Discounts Have Fraud Risks, Watchdog Says
A health care nonprofit's proposed use of drugmaker funds to help Medicare beneficiaries afford pricey medications would hike drug costs for taxpayers and warrant sanctions under the Anti-Kickback Statute, a U.S....To view the full article, register now.
Already a subscriber? Click here to view full article